The UK’s relationship with our European neighbours is the topic of increasingly heated debate as Thursday 23rd of June looms. The UK “referendum on Europe” is at times even usurping our enduring preoccupation with the weather.
Whatever the outcome, I am sure we as drug researchers, practitioners and concerned others will continue to find ways to work collaboratively around shared concerns which transgress national borders and boundaries, such as the health and wellbeing of all.
The EMCDDA is developing estimates of the size of drug markets across the European Union based on data provided by National Focal Points, which in the UK is Public Health England. One way of estimating market size is to collect survey data on quantities of substances used by different groups of people who take drugs. The EMCDDA’s European Web Survey on Drugs focuses on seven countries across Europe, namely Croatia, the Czech Republic, France, Latvia, the Netherlands, Switzerland and the United Kingdom.
Please spread the word, get involved, and make your views and experiences heard.